 IV. Profile differences in the type, number and density of Fc-receptors FcgammaR on MPS cells in blood of patients prior to and after administration of glembatumumab vedotin and nivolumab as a method to evaluate the factors affecting PK and pharmacodynamics PD variability and mechanisms of drug-drug interactions. 